Search research articles
Contact Us
Filters
Showing results (11-20 of 23) with videos related to
Page
of 3
Sort By:
Clinical Pharmacology and Therapeutics
|
December 1, 1978
Naproxen-probenecid interaction
R Runkel, E Mroszczak, M Chaplin, et al.
Clinical Pharmacology and Therapeutics
|
September 1, 1976
Pharmacokinetics of naproxen overdoses
R Runkel, M D Chaplin, H Sevelius, et al.
Clinical Pharmacology and Therapeutics
|
April 1, 1974
Naproxen-aspirin interactions in man
E J Segre, M Chaplin, E Forchielli, et al.
Scandinavian Journal of Rheumatology. Supplement
|
January 1, 1973
Interaction of naproxen and aspirin in the rat and in man
E Segre, H Sevelius, M Chaplin, et al.
European Journal of Clinical Pharmacology
|
June 1, 1973
Naproxen suppository: tissue response and comparative bioavailability
H Sevelius, R Runkel, A Pardo, et al.
Atherosclerosis
|
May 1, 1988
Reduction of serum lipoproteins in man by the oral administration of a prostaglandin analogue (enprostil)
K E Schwartz, B Zaro, P Burton, et al.
Pharmacotherapy
|
January 1, 1990
Ketorolac tromethamine pharmacokinetics and metabolism after intravenous, intramuscular, and oral administration in humans and animals
E J Mroszczak, D Jung, J Yee, et al.
Pharmaceutical Research
|
January 1, 1989
Pharmacokinetics of ketorolac and p-hydroxyketorolac following oral and intramuscular administration of ketorolac tromethamine
D Jung, E J Mroszczak, A Wu, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|
October 1, 1988
Suppression of postprandial glucose, insulin, C-peptide, and glucose-dependent insulinotropic peptide (GIP) in man by oral administration of a prostaglandin analogue (enprostil)
K E Schwartz, B Zaro, J Reynolds, et al.
Scandinavian Journal of Rheumatology. Supplement
|
January 1, 1973
Naproxen-metabolism, excretion and comparative pharmacokinetics
R Runkel, E Forchielli, G Boost, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 23) with videos related to
Sort By:
Page
of 3
Clinical Pharmacology and Therapeutics
|
December 1, 1978
Naproxen-probenecid interaction
R Runkel, E Mroszczak, M Chaplin, et al.
Clinical Pharmacology and Therapeutics
|
September 1, 1976
Pharmacokinetics of naproxen overdoses
R Runkel, M D Chaplin, H Sevelius, et al.
Clinical Pharmacology and Therapeutics
|
April 1, 1974
Naproxen-aspirin interactions in man
E J Segre, M Chaplin, E Forchielli, et al.
Scandinavian Journal of Rheumatology. Supplement
|
January 1, 1973
Interaction of naproxen and aspirin in the rat and in man
E Segre, H Sevelius, M Chaplin, et al.
European Journal of Clinical Pharmacology
|
June 1, 1973
Naproxen suppository: tissue response and comparative bioavailability
H Sevelius, R Runkel, A Pardo, et al.
Atherosclerosis
|
May 1, 1988
Reduction of serum lipoproteins in man by the oral administration of a prostaglandin analogue (enprostil)
K E Schwartz, B Zaro, P Burton, et al.
Pharmacotherapy
|
January 1, 1990
Ketorolac tromethamine pharmacokinetics and metabolism after intravenous, intramuscular, and oral administration in humans and animals
E J Mroszczak, D Jung, J Yee, et al.
Pharmaceutical Research
|
January 1, 1989
Pharmacokinetics of ketorolac and p-hydroxyketorolac following oral and intramuscular administration of ketorolac tromethamine
D Jung, E J Mroszczak, A Wu, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|
October 1, 1988
Suppression of postprandial glucose, insulin, C-peptide, and glucose-dependent insulinotropic peptide (GIP) in man by oral administration of a prostaglandin analogue (enprostil)
K E Schwartz, B Zaro, J Reynolds, et al.
Scandinavian Journal of Rheumatology. Supplement
|
January 1, 1973
Naproxen-metabolism, excretion and comparative pharmacokinetics
R Runkel, E Forchielli, G Boost, et al.
Page
of 3